Literature DB >> 18793853

bis-Pyridinium cyclophanes: novel ligands with high affinity for the blood-brain barrier choline transporter.

Zhenfa Zhang1, Paul R Lockman, Rajendar K Mittapalli, David D Allen, Linda P Dwoskin, Peter A Crooks.   

Abstract

A series of bis-pyridinium cyclophane analogs designed as conformationally restricted bis-quaternary ammonium compounds were evaluated for their affinity for the blood-brain barrier (BBB) choline transporter. All the cyclophanes investigated exhibited high affinity compared to choline. Of these compounds, N, N'-(1,10-decanediyl)3,3'-(1,9-decadiyn-1,10-diyl)-bis-pyridinium diiodide (5c) and N,N'-(1,9-nonanediyl)3,3'-(1,9-decadiyn-1,10-diyl)-bis-pyridinium dibromide (5b) exhibited highest affinity with K(i) values of 0.8 microM and 1.4 microM, respectively, and constitute some of the most potent BBB choline transporter ligands reported.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18793853      PMCID: PMC3437650          DOI: 10.1016/j.bmcl.2008.08.099

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  28 in total

Review 1.  In silico prediction models for blood-brain barrier permeation.

Authors:  Gerhard F Ecker; Christian R Noe
Journal:  Curr Med Chem       Date:  2004-06       Impact factor: 4.530

2.  Molecular modeling studies on the active binding site of the blood-brain barrier choline transporter.

Authors:  Werner J Geldenhuys; Paul R Lockman; James H McAfee; Kevin T Fitzpatrick; Cornelis J Van der Schyf; David D Allen
Journal:  Bioorg Med Chem Lett       Date:  2004-06-21       Impact factor: 2.823

3.  Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Peter A Crooks; Joshua T Ayers; Rui Xu; Sangeetha P Sumithran; Vladimir P Grinevich; Lincoln H Wilkins; A Gabriela Deaciuc; David D Allen; Linda P Dwoskin
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

Review 4.  Membrane transport of alkylating agents.

Authors:  G J Goldenberg; A Begleiter
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

5.  Rapid high-affinity transport of a chemotherapeutic amino acid across the blood-brain barrier.

Authors:  Y Takada; D T Vistica; N H Greig; D Purdon; S I Rapoport; Q R Smith
Journal:  Cancer Res       Date:  1992-04-15       Impact factor: 12.701

6.  Characterization of the blood-brain barrier choline transporter using the in situ rat brain perfusion technique.

Authors:  D D Allen; Q R Smith
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

7.  Evaluation of blood-brain barrier thiamine efflux using the in situ rat brain perfusion method.

Authors:  P R Lockman; R J Mumper; D D Allen
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

8.  Subtype-selective nicotinic receptor antagonists: potential as tobacco use cessation agents.

Authors:  Linda P Dwoskin; Sangeetha P Sumithran; Jun Zhu; A Gabriela Deaciuc; Joshua T Ayers; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2004-04-19       Impact factor: 2.823

Review 9.  The blood-brain barrier choline transporter as a brain drug delivery vector.

Authors:  D D Allen; P R Lockman
Journal:  Life Sci       Date:  2003-08-15       Impact factor: 5.037

10.  N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.

Authors:  Lincoln H Wilkins; Vladimir P Grinevich; Joshua T Ayers; Peter A Crooks; Linda P Dwoskin
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

View more
  5 in total

Review 1.  Nicotinic receptor antagonists as treatments for nicotine abuse.

Authors:  Peter A Crooks; Michael T Bardo; Linda P Dwoskin
Journal:  Adv Pharmacol       Date:  2014

2.  Peptidyl alpha-ketoamides with nucleobases, methylpiperazine, and dimethylaminoalkyl substituents as calpain inhibitors.

Authors:  Asli Ovat; Zhao Zhao Li; Christina Y Hampton; Seneshaw A Asress; Facundo M Fernández; Jonathan D Glass; James C Powers
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

Review 3.  Molecular determinants of blood-brain barrier permeation.

Authors:  Werner J Geldenhuys; Afroz S Mohammad; Chris E Adkins; Paul R Lockman
Journal:  Ther Deliv       Date:  2015-08-25

4.  In silico predictive model to determine vector-mediated transport properties for the blood-brain barrier choline transporter.

Authors:  Sergey Shityakov; Carola Förster
Journal:  Adv Appl Bioinform Chem       Date:  2014-09-02

5.  Novel bis-2,2,6,6-tetramethylpiperidine (bis-TMP) and bis-mecamylamine antagonists at neuronal nicotinic receptors mediating nicotine-evoked dopamine release.

Authors:  Zhenfa Zhang; Marharyta Pivavarchyk; Karunai Leela Subramanian; A Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem Lett       Date:  2010-01-04       Impact factor: 2.823

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.